The medical community is slowly warming to the use of cannabidiol (CBD) for a wide number of health concerns. Its utility includes well-known analgesic effects on cancer pain, but also extends to the treatment of gastroenterological and neuropsychiatric illnesses, and beyond.
Some obese patients don’t respond at all to treatments involving diet and exercise and for them, anti-obesity medicines are a necessity. But should South African doctors be prescribing medications containing pseudoephedrine for weight loss, when much better options abound?
Most doctors are familiar with generics, but studies show that many are not aware of what pseudo-generics or clones are. In addition, knowledge about the differences between biosimilars and biologics is restricted to those who use it regularly in clinical practice. In this article we discuss the different agents and share important prescription considerations.
The prevalence of actinic keratosis and superficial basal cell carcinoma make them some of the most commonly encountered dermatological conditions in a primary care setting. While they are easy to treat, concerns remain about their long-term clearance.
Studies show that the prevalence of AF ranges from 1% to 15% in people between the ages of 35 and 85. Age is a risk factor for AF, which means as life expectancy increases, the number of people with the condition will continue to rise. It is expected that by 2050, the prevalence of AF will increase by 250%.
Osteoarthritis (OA) is one of the leading causes of disability in the elderly. Changes in the lubricating properties of synovial fluid leads to significant pain and functional disability.
Allergies and allergic symptoms are rising have been rising in prevalence for decades, but there is growing dissatisfaction towards available therapies among doctors and laypeople alike. Naturally-occurring compounds like quercetin provide a safe, effective alternative.